Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bad Rothenfelde – page 2

897 clinical trials in Bad Rothenfelde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bad Rothenfelde at a glance
897
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

897 trials in Bad Rothenfelde

Open in trial search

Hidradenitis

Recruiting

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Orelabrutinib
  • Sponsor:Zenas Biopharma (USA) LLC

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.

A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Cold urticaria

Recruiting

A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Alopecia areata

Recruiting

A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:LAD603
  • Sponsor:Almirall S.A.

Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Eczema nummular

Recruiting

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim International GmbH

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim International GmbH

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Breast cancer

Recruiting

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bad Rothenfelde

What the registry says about research in the country

01 Cardiac Surgery Research

Innovative clinical trials focusing on managing perioperative bleeding during complex cardiac procedures. This research explores the effectiveness of fibrinogen concentrate in combination with standard care protocols.

  • Blood Management Studies
  • Cardiac Surgery Complications
  • Transfusion Medicine

These investigations aim to advance bleeding management strategies during cardiopulmonary bypass procedures, potentially reducing the need for blood transfusions in the critical 24-hour post-surgery period.

02 Cardiovascular Therapeutics

Current research evaluates novel hemostatic agents in cardiovascular surgery, comparing their efficacy against placebo in controlled clinical settings.

  • Blood Conservation
  • Surgical Hemostasis
  • Patient Safety

The studies focus on optimizing patient outcomes by developing improved protocols for managing surgical bleeding complications.

03 Transfusion Medicine

Groundbreaking research in blood product alternatives and their application in major cardiac surgeries. These trials evaluate modern approaches to reducing allogeneic transfusion requirements.

  • Blood Product Management
  • Transfusion Protocols
  • Clinical Outcomes

This research aims to establish more effective blood management strategies for complex cardiac surgical procedures.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.